Systematic review of the diagnostic accuracy of 201tl single photon emission computed tomography in the detection of recurrent glioma

Nuclear Medicine Communications

Volumn 28, Issue 6, 2007, Pages 431-439

  Vos, Maaike J ^a   Tony, Ban N ^a   Hoekstra, Otto S ^a   Postma, Tjeerd J ^a   Heimans, Jan J ^a   Hooft, Lotty ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

201Tl SPECT; Diagnostic accuracy; Glioma; Radiotherapy; Tumour recurrence

Indexed keywords

THALLIUM 201;

BRAIN TUMOR; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; GLIOMA; HUMAN; METHODOLOGY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; TUMOR RECURRENCE;

BRAIN NEOPLASMS; CLINICAL TRIALS; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34247563850     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328155d131     Document Type: Review

References (35)

1. Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 1999; 42:227-231.
2. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993; 26:239-244.
3. Metcalfe SE, Grant R. Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 2001; CD002034.
4. Walker MD, Alexander Jr E, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978; 49:333-343.
5. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47:649-652.
6. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71:2585-2597.
7. Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol 2001; 19:509-518.
8. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359:1011-1018.
9. Marks JE, Baglan RJ, Prassad SC, Blank WF. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 1981; 7:243-252.
10. Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF, et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 1994; 74:2828-2835.
11. Constine LS, Konski A, Ekholm S, McDonald S, Rubin P. Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 1988; 15:319-330.
12. Kumar AJ, Leeds NE, Fuller GN, van Tassel P, Maor MH, Sawaya RE, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217:377-384.
13. Byrne TN. Imaging of gliomas. Semin Oncol 1994; 21:162-171.
14. Kaplan RS. Complexities, pitfalls, and strategies for evaluating brain tumor therapies. Curr Opin Oncol 1998; 10:175-178.
15. Cairncross JG, Pexman JH, Rathbone MP, DelMaestro RF. Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 1985; 17:570-572.
16. Forsyth PA, Petrov E, Mahallati H, Cairncross JG, Brasher P, MacRae ME, et al. Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 1997; 15:2076-2081.
17. 201Tl SPET in the detection of recurrent brain tumours after radiation therapy. Nucl Med Commun 2002; 23:1183-1190.
18. Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, et al. The role of thallium-201 uptake and retention in intracranial tumors after radiotherapy. J Nucl Med 1997; 38:223-226.
19. Slizofski WJ, Krishna L, Katsetos CD, Black P, Miyamoto C, Brown SJ, et al. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 1994; 74:3190-3197.
20. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 1993; 7:257-263.
21. Carvalho PA, Schwartz RB, Alexander III E, Garada BM, Zimmerman RE, Loeffler JS, et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992; 77:565-570.
22. 99mTc-HMPAO. AJNR Am J Neuroradiol 1991; 12:1187-1192.
23. Mountz JM, Raymond PA, McKeever PE, Modell JG, Hood TW, Barthel LK, et al. Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989; 49:4053-4056.
24. Sasaki M, Ichiya Y, Kuwabara Y, Yoshida T, Inoue T, Morioka T, et al. Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity. J Nucl Med 1996; 37:1174-1176.
25. Yoshii Y, Moritake T, Suzuki K, Fujita K, Nose T, Satou M. Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. AJNR Am J Neuroradiol 1996; 17:1773-1776.
26. Deville WL, Bezemer PD, Bouter LM. Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. J Clin Epidemiol 2000; 53:65-69.
27. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61:215-225.
28. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12:1293-1316.
29. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2:9.
30. Lorberboym M, Baram J, Feibel M, Hercbergs A, Lieberman L. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden. Int J Radiat Oncol Biol Phys 1995; 32:249-254.
31. Kline JL, Noto RB, Glantz M. Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. AJNR Am J Neuroradiol 1996; 17:1681-1686.
32. 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol Med Chir (Tokyo) 1998; 38:342-347.
33. Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 1998; 89:60-68.
34. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282:1061-1066.
35. 201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis. Eur J Nucl Med Mol Imaging 2004; 31:1237-1243.